Search

Astellas Pharma Inc. US
  • Top MenuAbout
    U.S. Corporate Profile
    Learn more about Astellas U.S.
    Read More
    • Company Facts
      • Astellas Fact Sheet
      • Integrated Report
    • Contact Us
    • Ethics & Compliance
    • Governance
    • Group Code of Conduct
    • Locations
    • Philosophy
      • Charter of Corporate Conduct
    • Policies & Position Statements
    • Political Contributions
    • Regulations
      • State Regulations
        • California Declaration of Comprehensive Compliance Program
        • Vermont’s Pharmaceutical Marketer Price Disclosure
        • Wholesale Acquisition Cost Information for Colorado Prescribers
      • Consumer Product Safety Commission Regulations
    • U.S. Corporate Profile
      • Locations
    • U.S. Leadership
      • Joe Devaney
      • Lynn Fenicchia
      • Mark Reisenauer
      • Phil Tennant
      • Lei Ding
    • U.S. Products
      • Medical Safety
        • Safety Data Sheets (v 3.0)
    • Vision & Strategy
  • Top MenuInnovation
    Clinical Trials
    This website provides access to information from Astellas sponsored clinical trials and the purpose is not to promote or advertise any...
    Read More
    • Partnering
      • Track Record
      • Areas of Interest
      • Partnering Inquiry
    • R&D
      • Approach
      • Clinical Trials
      • Ethics & Principles
      • Pipeline
  • Top MenuSUSTAINABILITY
    Changing Tomorrow Day
    Read about our annual day of service.
    Read More
    • Access Accelerated
    • Changing Tomorrow Day
    • Corporate Grants
    • COVID-19 Community Response
    • Employee Impact
  • Top MenuNews
    Annual Report
    Read about our latest progress around our Corporate Strategic Plan.
    Read More
    • Annual Report
    • Articles
    • Media Inquiries
    • News Releases
      • Stories
      • Corporate
      • Corporate Awards
      • Corporate Social Responsibility
      • Our People
      • Therapeutic Area News
    • Statements
    • Video Gallery

Stakeholders menu

  • COVID-19 Response
  • Patient Focus
    • Support for Patients
      • Astellas Pharma Support Solutions
    • Issues that Matter to You
    • Patient Centricity
    • Patient Partnerships
    • U.S. Products
  • Careers
  • Partnering
  • Contact Us

Common header menu

  • IMPORTANT NOTICE
  • WORLDWIDE
  • US
  • WORLDWIDE - US
  1. Home
  2. About
  3. Regulations
  4. Consumer Product Safety Commission Regulations

Consumer Product Safety Commission Regulations

Important Notice

This website is intended for U.S. residents only. This website contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, or in different dosages. Nothing contained herein should be considered a solicitation, promotion or advertisement for any drug including those under development. Any information on the products contained herein is not intended to provide medical advice nor should be used as a substitute for the advice provided by your physician or other healthcare provider.

Close

The following General Conformity Certifications (GCC) for products that have child-resistant packaging are being provided pursuant to section 102(a)(1) of the Consumer Product Safety Improvement Act and in accordance with the Poison Prevention Packaging Act and implementing regulations. See 16 C.F.R. § 1700.14.

  • Astellas GCC Astagraf XL Capsules 28mm closures
  • Astellas GCC Astagraf XL Capsules 38mm closures
  • Astellas GCC Cresemba Capsules
  • Astellas GCC Myrbetriq container 1
  • Astellas GCC Myrbetriq container 2
  • Astellas GCC Myrbetriq Granules
  • Astellas GCC Prograf Capsules
  • Astellas GCC Prograf Granules
  • Astellas GCC Tarceva
  • Astellas GCC Vesicare
  • Astellas GCC Vesicare LS
  • Astellas GCC XOSPATA
  • ​Astellas GCC Xtandi Gelcap
  • Astellas GCC Xtandi Tablets

About

  • Company Facts
    • Astellas Fact Sheet
    • Integrated Report
  • Contact Us
  • Ethics & Compliance
  • Governance
  • Group Code of Conduct
  • Locations
  • Philosophy
    • Charter of Corporate Conduct
  • Policies & Position Statements
  • Political Contributions
  • Regulations
    • State Regulations
      • California Declaration of Comprehensive Compliance Program
      • Vermont’s Pharmaceutical Marketer Price Disclosure
      • Wholesale Acquisition Cost Information for Colorado Prescribers
    • Consumer Product Safety Commission Regulations
  • U.S. Corporate Profile
    • Locations
  • U.S. Leadership
    • Joe Devaney
    • Lynn Fenicchia
    • Mark Reisenauer
    • Phil Tennant
    • Lei Ding
  • U.S. Products
    • Medical Safety
      • Safety Data Sheets (v 3.0)
  • Vision & Strategy
Astellas LogoAstellas Changing Tomorrow

Follow us on social media

Facebook icon Linkedin icon Twitter icon

Bottom footer menu

  • SITE MAP
  • PRIVACY POLICY
  • COOKIES POLICY
  • ACCESSIBILITY
  • LEGAL DISCLAIMER
  • CONTACT US
© 2023 Astellas Pharma US, Inc.

Update Cookies Preferences